Cargando…

Statement on the active substance acetamiprid

Acetamiprid is a pesticide active substance with insecticidal action currently under the third renewal (AIR3) of the Commission implementing regulation (EU) No 844/2012. Following concerns that this substance may pose high risks to humans and the environment, the French authorities asked the Commiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez Jerez, Antonio, Adriaanse, Paulien, Berny, Philippe, Coja, Tamara, Duquesne, Sabine, Focks, Andreas, Marinovich, Marina, Millet, Maurice, Pelkonen, Olavi, Pieper, Silvia, Tiktak, Aaldrik, Topping, Christopher, Widenfalk, Anneli, Wilks, Martin, Wolterink, Gerrit, Rundlöf, Maj, Ippolito, Alessio, Linguadoca, Alberto, Martino, Laura, Panzarea, Martina, Terron, Andrea, Aldrich, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784984/
https://www.ncbi.nlm.nih.gov/pubmed/35106090
http://dx.doi.org/10.2903/j.efsa.2022.7031
_version_ 1784638859889344512
author Hernandez Jerez, Antonio
Adriaanse, Paulien
Berny, Philippe
Coja, Tamara
Duquesne, Sabine
Focks, Andreas
Marinovich, Marina
Millet, Maurice
Pelkonen, Olavi
Pieper, Silvia
Tiktak, Aaldrik
Topping, Christopher
Widenfalk, Anneli
Wilks, Martin
Wolterink, Gerrit
Rundlöf, Maj
Ippolito, Alessio
Linguadoca, Alberto
Martino, Laura
Panzarea, Martina
Terron, Andrea
Aldrich, Annette
author_facet Hernandez Jerez, Antonio
Adriaanse, Paulien
Berny, Philippe
Coja, Tamara
Duquesne, Sabine
Focks, Andreas
Marinovich, Marina
Millet, Maurice
Pelkonen, Olavi
Pieper, Silvia
Tiktak, Aaldrik
Topping, Christopher
Widenfalk, Anneli
Wilks, Martin
Wolterink, Gerrit
Rundlöf, Maj
Ippolito, Alessio
Linguadoca, Alberto
Martino, Laura
Panzarea, Martina
Terron, Andrea
Aldrich, Annette
collection PubMed
description Acetamiprid is a pesticide active substance with insecticidal action currently under the third renewal (AIR3) of the Commission implementing regulation (EU) No 844/2012. Following concerns that this substance may pose high risks to humans and the environment, the French authorities asked the Commission to restrict its uses under Article 69 of Regulation (EC) No 1107/2009. To support this request, competent Authorities from France cited a series of literature papers investigating its hazards and/or exposure to humans and the environment. Consequently, the EFSA PPR Panel was mandated to advise on the likelihood that body of evidence would constitute proof of serious risks to humans or the environment. Therefore, the EFSA PPR Panel evaluated the likelihood of these studies indicating new or higher hazards and exposure to humans and the environment compared to previous EU assessments.A stepwise methodology was designed, including: (i) the initial screening; (ii) the data extraction and critical appraisal based on the principles of OHAT/NTP; (iii) the weight of evidence, including consideration of the previous EU assessments; (iv) the uncertainty analysis, followed, whenever relevant, by an expert knowledge elicitation process. For human health, no conclusive evidence of higher hazards compared to previous assessment was found for genotoxicity, developmental toxicity, neurotoxicity including developmental neurotoxicity and immunotoxicity. However, due to the lack of adequate assessment of the current data set, the PPR Panel recommends conducting an assessment of endocrine disrupting properties for acetamiprid in line with EFSA/ECHA guidance document for the identification of endocrine disruptors. For environment, no conclusive, robust evidence of higher hazards compared to the previous assessment was found for birds, aquatic organisms, bees and soil organisms. However, the potential of high inter‐species sensitivity of birds and bees towards acetamiprid requires further consideration.
format Online
Article
Text
id pubmed-8784984
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87849842022-01-31 Statement on the active substance acetamiprid Hernandez Jerez, Antonio Adriaanse, Paulien Berny, Philippe Coja, Tamara Duquesne, Sabine Focks, Andreas Marinovich, Marina Millet, Maurice Pelkonen, Olavi Pieper, Silvia Tiktak, Aaldrik Topping, Christopher Widenfalk, Anneli Wilks, Martin Wolterink, Gerrit Rundlöf, Maj Ippolito, Alessio Linguadoca, Alberto Martino, Laura Panzarea, Martina Terron, Andrea Aldrich, Annette EFSA J Statement Acetamiprid is a pesticide active substance with insecticidal action currently under the third renewal (AIR3) of the Commission implementing regulation (EU) No 844/2012. Following concerns that this substance may pose high risks to humans and the environment, the French authorities asked the Commission to restrict its uses under Article 69 of Regulation (EC) No 1107/2009. To support this request, competent Authorities from France cited a series of literature papers investigating its hazards and/or exposure to humans and the environment. Consequently, the EFSA PPR Panel was mandated to advise on the likelihood that body of evidence would constitute proof of serious risks to humans or the environment. Therefore, the EFSA PPR Panel evaluated the likelihood of these studies indicating new or higher hazards and exposure to humans and the environment compared to previous EU assessments.A stepwise methodology was designed, including: (i) the initial screening; (ii) the data extraction and critical appraisal based on the principles of OHAT/NTP; (iii) the weight of evidence, including consideration of the previous EU assessments; (iv) the uncertainty analysis, followed, whenever relevant, by an expert knowledge elicitation process. For human health, no conclusive evidence of higher hazards compared to previous assessment was found for genotoxicity, developmental toxicity, neurotoxicity including developmental neurotoxicity and immunotoxicity. However, due to the lack of adequate assessment of the current data set, the PPR Panel recommends conducting an assessment of endocrine disrupting properties for acetamiprid in line with EFSA/ECHA guidance document for the identification of endocrine disruptors. For environment, no conclusive, robust evidence of higher hazards compared to the previous assessment was found for birds, aquatic organisms, bees and soil organisms. However, the potential of high inter‐species sensitivity of birds and bees towards acetamiprid requires further consideration. John Wiley and Sons Inc. 2022-01-24 /pmc/articles/PMC8784984/ /pubmed/35106090 http://dx.doi.org/10.2903/j.efsa.2022.7031 Text en © 2022 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle Statement
Hernandez Jerez, Antonio
Adriaanse, Paulien
Berny, Philippe
Coja, Tamara
Duquesne, Sabine
Focks, Andreas
Marinovich, Marina
Millet, Maurice
Pelkonen, Olavi
Pieper, Silvia
Tiktak, Aaldrik
Topping, Christopher
Widenfalk, Anneli
Wilks, Martin
Wolterink, Gerrit
Rundlöf, Maj
Ippolito, Alessio
Linguadoca, Alberto
Martino, Laura
Panzarea, Martina
Terron, Andrea
Aldrich, Annette
Statement on the active substance acetamiprid
title Statement on the active substance acetamiprid
title_full Statement on the active substance acetamiprid
title_fullStr Statement on the active substance acetamiprid
title_full_unstemmed Statement on the active substance acetamiprid
title_short Statement on the active substance acetamiprid
title_sort statement on the active substance acetamiprid
topic Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784984/
https://www.ncbi.nlm.nih.gov/pubmed/35106090
http://dx.doi.org/10.2903/j.efsa.2022.7031
work_keys_str_mv AT statementontheactivesubstanceacetamiprid
AT hernandezjerezantonio statementontheactivesubstanceacetamiprid
AT adriaansepaulien statementontheactivesubstanceacetamiprid
AT bernyphilippe statementontheactivesubstanceacetamiprid
AT cojatamara statementontheactivesubstanceacetamiprid
AT duquesnesabine statementontheactivesubstanceacetamiprid
AT focksandreas statementontheactivesubstanceacetamiprid
AT marinovichmarina statementontheactivesubstanceacetamiprid
AT milletmaurice statementontheactivesubstanceacetamiprid
AT pelkonenolavi statementontheactivesubstanceacetamiprid
AT piepersilvia statementontheactivesubstanceacetamiprid
AT tiktakaaldrik statementontheactivesubstanceacetamiprid
AT toppingchristopher statementontheactivesubstanceacetamiprid
AT widenfalkanneli statementontheactivesubstanceacetamiprid
AT wilksmartin statementontheactivesubstanceacetamiprid
AT wolterinkgerrit statementontheactivesubstanceacetamiprid
AT rundlofmaj statementontheactivesubstanceacetamiprid
AT ippolitoalessio statementontheactivesubstanceacetamiprid
AT linguadocaalberto statementontheactivesubstanceacetamiprid
AT martinolaura statementontheactivesubstanceacetamiprid
AT panzareamartina statementontheactivesubstanceacetamiprid
AT terronandrea statementontheactivesubstanceacetamiprid
AT aldrichannette statementontheactivesubstanceacetamiprid